2021 Q2 Form 10-Q Financial Statement

#000121390021028342 Filed on May 21, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 Q1 2020 Q2
Revenue $4.907M $4.014M $3.004M
YoY Change 63.36% 30.73% -17.03%
Cost Of Revenue $1.914M $1.454M $1.819M
YoY Change 5.27% 4.15% 68.39%
Gross Profit $2.993M $2.560M $1.185M
YoY Change 152.52% 52.89% -53.34%
Gross Profit Margin 60.99% 63.77% 39.45%
Selling, General & Admin $6.202M $3.589M $5.243M
YoY Change 18.29% -36.8% -60.1%
% of Gross Profit 207.26% 140.2% 442.43%
Research & Development $1.527M $1.424M $1.089M
YoY Change 40.25% 62.79% -59.52%
% of Gross Profit 51.04% 55.63% 91.89%
Depreciation & Amortization $1.317M $1.053M $1.320M
YoY Change -0.23% 37183.36%
% of Gross Profit 44.01% 41.13% 111.39%
Operating Expenses $9.044M $6.066M $7.368M
YoY Change 22.73% -7.43% -12.18%
Operating Profit -$6.051M -$3.506M -$6.183M
YoY Change -2.14% -28.14% 5.7%
Interest Expense -$163.1K $776.2K -$2.084K
YoY Change 7727.5% -110.42%
% of Operating Profit
Other Income/Expense, Net -$46.16K -$2.942M $157.0K
YoY Change -129.41% -1188.23%
Pretax Income -$6.097M -$6.448M -$6.026M
YoY Change 1.17% 39.91% 3.55%
Income Tax $4.300K $6.270K $30.99K
% Of Pretax Income
Net Earnings -$6.105M -$6.458M -$5.313M
YoY Change 14.92% 43.27% -8.72%
Net Earnings / Revenue -124.42% -160.88% -176.87%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.25 -$290.9K -$221.6K
COMMON SHARES
Basic Shares Outstanding 24.14M shares
Diluted Shares Outstanding 24.53M shares

Balance Sheet

Concept 2021 Q2 2021 Q1 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.78M $15.43M $24.16M
YoY Change -51.25% 7.83% 10.47%
Cash & Equivalents $11.80M $15.43M $24.16M
Short-Term Investments
Other Short-Term Assets $2.673M $2.040M $1.710M
YoY Change 56.29% -9.73% 58.33%
Inventory
Prepaid Expenses $2.395M $2.096M $1.215M
Receivables $1.798M $1.887M $1.862M
Other Receivables $231.1K $550.0K $0.00
Total Short-Term Assets $16.48M $19.91M $27.73M
YoY Change -40.58% 11.23% 14.59%
LONG-TERM ASSETS
Property, Plant & Equipment $53.35K $1.140M $131.1K
YoY Change -59.3% 1528.13%
Goodwill $46.79M $41.87M $20.25M
YoY Change 131.01%
Intangibles
YoY Change
Long-Term Investments $226.1K $230.0K $250.0K
YoY Change -9.56% -8.0%
Other Assets $41.93K
YoY Change
Total Long-Term Assets $60.06M $54.42M $30.80M
YoY Change 95.0% 132.07%
TOTAL ASSETS
Total Short-Term Assets $16.48M $19.91M $27.73M
Total Long-Term Assets $60.06M $54.42M $30.80M
Total Assets $76.53M $74.33M $58.53M
YoY Change 30.76% 79.76% 141.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.126M $495.8K $1.444M
YoY Change -21.98% -87.7% 9.59%
Accrued Expenses $3.555M $2.560M $3.420M
YoY Change 3.95% 584.0%
Deferred Revenue
YoY Change
Short-Term Debt $2.000M $0.00 $0.00
YoY Change
Long-Term Debt Due $7.156M $8.780M $6.140M
YoY Change 16.55%
Total Short-Term Liabilities $13.37M $13.44M $11.75M
YoY Change 13.76% 181.66% 381.27%
LONG-TERM LIABILITIES
Long-Term Debt $1.201M $1.130M $10.20M
YoY Change -88.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.201M $1.130M $10.20M
YoY Change -88.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.37M $13.44M $11.75M
Total Long-Term Liabilities $1.201M $1.130M $10.20M
Total Liabilities $14.57M $14.56M $23.01M
YoY Change -36.68% 52.81% 319.61%
SHAREHOLDERS EQUITY
Retained Earnings -$69.74M -$63.64M -$41.15M
YoY Change 69.46% 49.21%
Common Stock $123.9M $110.9M $71.90M
YoY Change 72.26% 55.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.96M $59.77M $35.52M
YoY Change
Total Liabilities & Shareholders Equity $76.53M $74.33M $58.53M
YoY Change 30.76% 79.76% 141.84%

Cashflow Statement

Concept 2021 Q2 2021 Q1 2020 Q2
OPERATING ACTIVITIES
Net Income -$6.105M -$6.458M -$5.313M
YoY Change 14.92% 43.27% -8.72%
Depreciation, Depletion And Amortization $1.317M $1.053M $1.320M
YoY Change -0.23% 37183.36%
Cash From Operating Activities -$2.345M -$1.374M -$2.750M
YoY Change -14.72% -69.61% 2.23%
INVESTING ACTIVITIES
Capital Expenditures -$1.305M -$700.0K -$3.260M
YoY Change -59.98%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$140.0K
YoY Change -100.0% -100.74%
Cash From Investing Activities -$1.305M -$704.6K -$3.400M
YoY Change -61.63% 26.48% -118.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.850K -$333.8K 15.98M
YoY Change -100.02%
NET CHANGE
Cash From Operating Activities -2.345M -$1.374M -2.750M
Cash From Investing Activities -1.305M -$704.6K -3.400M
Cash From Financing Activities -3.850K -$333.8K 15.98M
Net Change In Cash -3.654M -$2.414M 9.830M
YoY Change -137.17% -46.01% -39.13%
FREE CASH FLOW
Cash From Operating Activities -$2.345M -$1.374M -$2.750M
Capital Expenditures -$1.305M -$700.0K -$3.260M
Free Cash Flow -$1.041M -$673.8K $510.0K
YoY Change -304.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1753547 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1990 USD
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77169072 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000 USD
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
227718 USD
CY2021Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
214036 USD
CY2021Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6974546 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1105869 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
843900 USD
CY2021Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
487372 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2095614 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
110903949 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74329176 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2458727 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3060746 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
94086433 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-91497 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16051215 USD
CY2020Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
11707363 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17840640 USD
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23067517 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
57222620 USD
CY2021Q1 kern Net Investment Non Current
NetInvestmentNonCurrent
229883 USD
CY2021Q1 kern Exchangable Preferred Stock
ExchangablePreferredStock
12601744 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
19909466 USD
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2306 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1139689 USD
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3506003 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4507212 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
2559857 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
776181 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
270315 USD
CY2020Q1 us-gaap Revenues
Revenues
3070546 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
180229 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-101175 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4878702 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6447651 USD
CY2021Q1 us-gaap Interest Income Other
InterestIncomeOther
1801 USD
CY2020Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
236917 USD
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22209072 shares
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1735915 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2040751 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
286637 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4470901 USD
CY2020Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
CY2021Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
USD
CY2020Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
USD
CY2020Q4 us-gaap Liabilities
Liabilities
19946452 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3188576 USD
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24136076 shares
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57179525 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13435289 USD
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7388795 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3925739 USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Goodwill
Goodwill
41874527 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63637228 USD
CY2020Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
3895237 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1887093 USD
CY2021Q1 us-gaap Liabilities
Liabilities
14563132 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3782 USD
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001755953
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity File Number
EntityFileNumber
001-39096
CY2020Q4 us-gaap Goodwill
Goodwill
41874527 USD
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 us-gaap Assets
Assets
74329176 USD
CY2021Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
1127843 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
311376 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
177832 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
USD
CY2021Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
7704545 USD
CY2020Q2 us-gaap Convertible Debt
ConvertibleDebt
17000000 USD
CY2021Q1 kern Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
13000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14809996 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1193433 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
1674327 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1052883 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
6065860 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2021Q1 us-gaap Revenues
Revenues
4014024 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
1396219 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3457262 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1424100 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4608387 USD
CY2020Q4 kern Net Investment Non Current
NetInvestmentNonCurrent
233664 USD
CY2021Q1 us-gaap Nature Of Operations
NatureOfOperations
<div> <div style="border-left: none; border-right: none;"> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 - Description of Business, Liquidity and Capital <font><font><font>Resources</font></font></font></font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Description of Business</font></p> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Akerna Corp., herein referred to as we, us our or Akerna, through our wholly owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, and solo sciences, inc, or Solo, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses&#8217; compliance with state regulations and to help state-licensed businesses operate in compliance with such law. We provide our commercial software platform, MJ Platform<font style="font-size: 8pt;"><sup>&#174;</sup></font>and Trellis<font style="font-size: 8pt;"><sup>&#174;</sup></font>&nbsp;to state-licensed businesses, and our regulatory software platform, Leaf Data Systems<font style="font-size: 8pt;"><sup>&#174;</sup></font>, to state government regulatory agencies. Through Solo,</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">&nbsp;</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG</font><font style="font-family: 'Times New Roman'; font-size: 8pt; vertical-align: super; line-height: inherit;">&#8482;</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">. The integration of MJ Platform<font style="font-size: 8pt;"><sup>&#174;</sup></font> and solo*CODE</font><font style="font-family: 'Times New Roman'; font-size: 8pt; vertical-align: super; line-height: inherit;">&#8482; </font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">results in technology for consumers and brands that brings a consumer-facing mark designed to highlight the authenticity and signify transparency. </font></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><font style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt;">&nbsp;</font><br/></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations.&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><br/></font></font></p> <p style="margin: 0pt; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Liquidity and <font style="line-height: inherit;">Capital <font style="line-height: inherit;">Resources</font></font></font></p> <p style="margin: 0pt; text-indent: 0pt; line-height: 1.4;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><br/></font></font></p> <p style="margin: 0pt; text-indent: 33.3333pt; line-height: 1.3;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Since our i<font style="line-height: inherit;">nception</font>, we have incurred recurring operating losses, used cash from operations, and relied on capital raising transactions to continue ongoing operations. During the three months ended March 31, 2021, we incurred a loss from operations of $<font>3.5</font> million and used cash in operations of $<font>1.4</font> million.<font style="line-height: inherit;">&nbsp; </font>As of March 31, 2021, we had cash of $<font style="line-height: inherit;"><font>15.4</font>&nbsp;</font>million, excluding restricted cash, and working capital of $<font>6.5</font> million.</font></font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;">&nbsp;</font></p> <p style="margin: 0pt;text-align: justify;line-height: 1.3;text-indent: 33.3333pt;font-family: 'Times New Roman';font-size: 10pt;"><font style="font-size: 10pt; text-indent: 25pt; line-height: inherit;">During <font>2020</font>, we implemented a number of cost reduction initiatives reducing&nbsp;<font style="border-left: none; border-right: none;">costs and identifying cost savings that we expect to result in annual savings of an additional $<font>3.0</font>&nbsp;million to $<font>4.0</font>&nbsp;million</font>, primarily a result of a reduction in workforce. On December 23, 2020, we entered into waivers with all the holders of our outstanding senior secured convertible notes. We&nbsp;may now elect, to pay installment amounts under the Notes prior to April 1, 2021, by issuing shares of common stock pursuant to installment conversions or by paying cash. On February 2, 2021, we agreed, in connection with the Company&#8217;s installment notice for the February 1, 2021 installment amount, to increase the installment amount for February 1, 2021, in the aggregate, by $<font>4,400,000</font>. From February 11, 2021 through March 10, 2021, we issued shares of common stock of </font>Akerna<font style="font-size: 10pt; text-indent: 25pt; line-height: inherit;"> to the holders of </font>Akerna&#8217;s<font style="font-size: 10pt; text-indent: 25pt; line-height: inherit;"> convertible notes upon conversion of installment amounts. As of March 31, 2021, the principal balance of the senior secured convertible notes was $<font>7.5</font>&nbsp;million, which we can settle in cash or&nbsp;by issuing shares at the company's&nbsp; election.</font></p> </div> <div> <div style="border-left: none; border-right: none;"> <p style="margin: 0cm; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font lang="EN-US" style="font-size: 10.0pt;">&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3;"><font lang="EN-US" style="font-size: 10pt; line-height: inherit;"></font><font lang="EN-US" style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">After considering all available evidence, we determined that, due to our current positive working capital, our ability to repay our senior secured convertible note with shares of our common stock, and our initiatives to reduce operating expenditures, that we have sufficient working capital to sustain operations for a period of at least&nbsp;<font>twelve</font>&nbsp;months from the date that our March 31, 2021&nbsp;financial statements were issued. Management will continue to evaluate our liquidity and capital resources.</font><font lang="EN-US" style="font-size: 10pt; line-height: inherit;"></font></p> <p style="margin: 0pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt;"><font lang="EN-US" style="font-size: 10.0pt;">&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3;"><font lang="EN-US" style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">From time to time, we may pursue various strategic business opportunities. These opportunities may include investment in or ownership of additional technology companies through direct investments, acquisitions, joint ventures, and other arrangements. We can provide no assurance that we will successfully identify such opportunities or that, if we identify and pursue any of these opportunities, any of them will be consummated. Consequently, we may raise additional equity or debt capital or enter into arrangements to secure the necessary financing to fund the completion of such strategic business opportunities, although no assurance can be provided that we will be successful in completing a future capital raise.&nbsp;The sale of additional equity could result in additional dilution to our existing stockholders, and financing arrangements may not be available to us, or may not be available in sufficient amounts or on acceptable terms. Our future operating performance will be subject to future economic conditions and to financial, business, and other factors, many of which are beyond our control.</font></p> </div> </div> </div>
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
975312 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2021Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
769773 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2824 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
USD
CY2021Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
8467292 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2941648 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1852962 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6270 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-236339 USD
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
377325 USD
CY2020Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
604851 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
58925 USD
CY2020Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1579 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15426759 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-230 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-704637 USD
CY2020Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
53621 USD
CY2021Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
7803475 USD
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Akerna Corp.
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
8781302 USD
CY2020Q4 kern Exchangable Preferred Stock
ExchangablePreferredStock
20405219 USD
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19901248 shares
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-101237 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-4608387 USD
CY2020Q2 us-gaap Noncurrent Assets
NoncurrentAssets
15068000 USD
CY2021Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
4773000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8771020 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6214579 shares
CY2021Q1 us-gaap Noncurrent Assets
NoncurrentAssets
16584000 USD
CY2021Q1 kern Cost Reduction Initiatives Description
CostReductionInitiativesDescription
cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $3.0 million to $4.0 million.
CY2021Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4201065 USD
CY2020Q1 kern Amortization Of Deferred Contract Costs
AmortizationOfDeferredContractCosts
USD
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
704637 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
333847 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
USD
CY2021Q1 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
3782 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19280897 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-10516 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15926759 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-101340 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18340640 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
152455 USD
CY2020Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
301948 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-333847 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-557132 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
208729 USD
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
503379 USD
CY2021Q1 kern Amortization Of Deferred Contract Costs
AmortizationOfDeferredContractCosts
118519 USD
CY2020Q1 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6457703 USD
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12469737 shares
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-124 USD
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23067517 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-104727 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6470933 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
59766044 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
301948 USD
CY2020Q1 kern Common Shares Issued In Exchange For Interest Inconsolidated Subsidiary
CommonSharesIssuedInExchangeForInterestInconsolidatedSubsidiary
17550000 USD
CY2020Q1 kern Noncontrolling Interests In Acquired Subsidiary
NoncontrollingInterestsInAcquiredSubsidiary
4863433 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
503379 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
333847 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57222620 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
USD
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><font style="font-family: 'times new roman', times; line-height: inherit;"><b><i><font lang="EN-US" style="font-size: 10pt; line-height: inherit;">Concentrations of Credit Risk</font></i></b></font></p> <p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><font lang="EN-US" style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;"><br/></font></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><font lang="EN-US" style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk.&nbsp;</font></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3;"><font lang="EN-US" style="font-size: 10pt; color: #000000; line-height: inherit;"><font style="font-family: 'times new roman', times; background-color: #ffff00; line-height: inherit;"><br/></font></font></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><font lang="EN-US" style="font-size: 10pt; color: #000000; line-height: inherit;"><font style="font-family: 'times new roman', times; line-height: inherit;">During the three months ended&nbsp;March 31, 2021 and <font>2020</font>,&nbsp;<font>one</font>&nbsp;government client accounted for&nbsp;<font style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;"><font>12</font><font style="line-height: inherit;">%</font></font><font style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;"> and <font>25</font>% of total revenues, respectively.&nbsp;As of March 31, 2021 and December 31, 2020,&nbsp;</font><font>two</font>&nbsp;government clients accounted for a total of&nbsp;<font style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;"><font>34</font></font>% and <font>36</font>%&nbsp;of net accounts receivable, respectively.&nbsp;</font></font></p> </div>
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1991272 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
6553029 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
874787 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
1454167 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4608387 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
18801 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1052882 USD
CY2021Q1 kern Preferred Stock Liquidation Description
PreferredStockLiquidationDescription
special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $1.00.
CY2020Q4 us-gaap Assets Current
AssetsCurrent
22552914 USD
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19901248 shares
CY2021Q1 kern Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
800000 USD
CY2021Q1 kern Unsatisfiedperformanceobligations
Unsatisfiedperformanceobligations
1100000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
214000 USD
CY2021Q1 kern Amortized Costs
AmortizedCosts
-119000 USD
CY2021Q1 us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
105000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
228000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
844000 USD
CY2021Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
4014000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
582000 USD
CY2021Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
3752000 USD
CY2020Q1 kern Adjustedforadoption
Adjustedforadoption
3071000 USD
CY2021Q1 kern Adjustedforadoption
Adjustedforadoption
4014000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
0.0001
CY2021Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-6717000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
319989 USD
CY2021Q1 kern Accrued Contractors
AccruedContractors
1172404 USD
CY2021Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
266086 USD
CY2021Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
294029 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
512419 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
495819 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
531654 USD
CY2020Q4 kern Accrued Contractors
AccruedContractors
1281857 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
311379 USD
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
216367 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
333709 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
513610 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2458727 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
68495 USD
CY2020Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
612446 USD
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
243222 USD
CY2020Q4 kern Prepaid Professional Fees
PrepaidProfessionalFees
826195 USD
CY2020Q4 kern Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
480651 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2095614 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
54303 USD
CY2021Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
549730 USD
CY2021Q1 us-gaap Prepaid Insurance
PrepaidInsurance
118762 USD
CY2021Q1 kern Prepaid Professional Fees
PrepaidProfessionalFees
653104 USD
CY2021Q1 kern Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
505679 USD
CY2021Q1 kern Stock Issued During Period Change In Fair Value Of Debt
StockIssuedDuringPeriodChangeInFairValueOfDebt
-13000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
8467500 USD
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2021Q1 us-gaap Secured Debt
SecuredDebt
7500000 USD
CY2021Q1 kern Installment Amount
InstallmentAmount
4400000 USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3071000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4014000 USD
CY2021Q1 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
0 USD
CY2021Q1 kern Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
377325 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19773131 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37880125 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59766044 USD
CY2021Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-230 USD
CY2020Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
CY2020Q4 kern Litigation Of Business Description
LitigationOfBusinessDescription
TechMagic USA LLC filed suit against our wholly-owned subsidiary, Solo, in Massachusetts Superior Court, Department Business Litigation, seeking recovery of up to approximately $1.07 million for unpaid invoices pursuant to a Master Services Agreement dated February 5, 2018 by and between TechMagic and Solo. The invoices set forth services that TechMagic USA LLC purports to have provided to Solo regarding development of mobile software applications for MJF and Solo between March and November 2020 totaling approximately $787,000. During our fiscal year ended June 30, 2020, we received invoices totaling an aggregate amount of approximately $392,000. After our year ended June 30, 2020, through December 31, 2020, we have received invoices totaling an aggregate amount of approximately $395,000. The suit seeks continued fees under the Master Services Agreement through the end of January 2021. Akerna provided a notice of termination of the Master Services Agreement on November 23, 2020 and the parties dispute the effective date of the termination. Solo disputes the validity of the invoices, in whole or in part, and intends to defend the suit vigorously. Mr. Ashesh Shah, formerly the president of Solo and currently the holder of 5.1% of our issued and outstanding shares of common stock is, to our knowledge, the founder and one of the principal managers of TechMagic USA LLC. As of March 31, 2021 and December 31, 2020, we recognized a loss contingency of $0.6 million.
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
631319 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2413881 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-234203 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Assets
Assets
77169072 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2020Q1 us-gaap Interest Income Other
InterestIncomeOther
33522 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1962034 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-14419027 USD
CY2019Q2 us-gaap Liabilities
Liabilities
5484503 USD
CY2020Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1058228 USD
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2015812 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
71902474 USD
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.14
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46299233 USD
CY2019Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3042000 USD
CY2021Q1 kern Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
1991272 USD
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
7697727 USD
CY2020Q2 kern Debt Purchase Price
DebtPurchasePrice
15000000 USD
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><font style="font-family: 'times new roman', times; line-height: inherit;"><b><i><font lang="EN-US" style="font-size: 10pt; line-height: inherit;">Reclassifications and Revisions</font></i></b><font lang="EN-US" style="font-size: 10pt; line-height: inherit;"></font></font></p> <p style="margin: 0pt; text-align: justify; line-height: 1.3; font-size: 7pt;"><font style="font-family: 'Times New Roman'; font-size: 7pt; line-height: inherit;">&nbsp;</font></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3; text-indent: 33.3333pt; text-align: justify;"><font lang="EN-US" style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation.</font></p> </div>
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-13572311 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2020Q2 us-gaap Liabilities
Liabilities
23013441 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27582558 USD
us-gaap Net Income Loss
NetIncomeLoss
-16210482 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41154869 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3979230 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
746852 USD
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
762646 USD
CY2020Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
13398000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><font style="font-family: 'times new roman', times;"><b><i><font lang="EN-US" style="font-size: 10.0pt;">Use of Estimates</font></i></b></font></p> <p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><font style="font-family: 'times new roman', times; line-height: inherit;"><b><i><font lang="EN-US" style="font-size: 10pt; line-height: inherit;"><br/></font></i></b></font></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt;"><font style="font-family: 'times new roman', times; line-height: inherit;"><b><i><font lang="EN-US" style="font-size: 10pt; line-height: inherit;"></font></i></b></font><font lang="EN-US" style="font-size: 10pt; line-height: inherit;"><font style="font-family: 'times new roman', times; line-height: inherit;">The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. <font style="color: #000000; line-height: inherit;">We base our estimates on assumptions that we believe to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources.</font> Actual results could differ materially from those estimates <font style="color: #000000; line-height: inherit;">under different assumptions or conditions; however, we believe that our estimates are reasonable</font>.&nbsp;&nbsp;</font></font></p> </div>

Files In Submission

Name View Source Status
0001213900-21-028342-index-headers.html Edgar Link pending
0001213900-21-028342-index.html Edgar Link pending
0001213900-21-028342.txt Edgar Link pending
0001213900-21-028342-xbrl.zip Edgar Link pending
ex101_1.htm Edgar Link pending
ex311_2.htm Edgar Link pending
ex312_3.htm Edgar Link pending
ex321_4.htm Edgar Link pending
ex322_5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kern-20210331.xml Edgar Link completed
kern-20210331.xsd Edgar Link pending
kern-20210331_cal.xml Edgar Link unprocessable
kern-20210331_def.xml Edgar Link unprocessable
kern-20210331_lab.xml Edgar Link unprocessable
kern-20210331_pre.xml Edgar Link unprocessable
MainDocument.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending